Why the study?
CAD is increasingly seen in younger populations, but routine lipid profiles do not incorporate emerging markers like Lp(a), ApoB, and ApoA1 that may show marked derangement.
Are elevated levels of Lp(a), ApoB, and ApoB/ApoA1 ratio associated with a higher risk of early-onset acute coronary syndrome in individuals aged 15-55 years?
Are elevated levels of Lp(a), ApoB, and ApoB/ApoA1 ratio associated with a higher risk of early-onset acute coronary syndrome in individuals aged 15-55 years?
Complementing traditional lipid profiles with ApoB, ApoB/ApoA1 ratio, and Lp(a) may improve the prediction of early-onset acute coronary syndrome in younger individuals.
Elevated Lp(a), ApoB, and ApoB/ApoA1 may flag early ACS risk in younger adults; leaves open routine clinical adoption pending prospective validation.
BACKGROUND of coronary artery disease is higher in elderly population (>60 years) , it is increasingly seen in younger population due to change in lifestyle. a [Lp(a)], Apolipoprotein B (ApoB) and Apolipoprotein A1 are among emerging markers for acute coronary syndrome (ACS). Routine lipid profile not incorporate these markers and cardiovascular diseases (CVD) in young who show marked derangement in their blood biochemical profile. In study we assessed Lp(a), ApoB, ApoA1 and ApoB/ApoA1 ratio in non-elderly and compared it with routine lipid profile. is a cross-sectional study comprising of 75 cases and 69 controls between 15- 55 years of age from whom morning fasting blood samples were collected and for lipid profile, Lp(a), ApoB, ApoA1 and ApoB/ApoA1 ratio. found that all the parameters in routine lipid profile as well as Lp(a), ApoB and /ApoA1 were significantly elevated in cases compared to controls. However, risk of developing early onset acute coronary syndrome is high in the presence non-routine markers like Lp(a) [Odds Ratio (OR)=11.71], ApoB (OR=11.70) and /ApoA1 (OR=11.74). study suggests that complementing the traditional lipid profile with ApoB, /ApoA1 and Lp(a) would be favourable additions for predicting early onset .
No takes yet. Share an insight, caveat, or question.
James et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: